Comparison of the new oral P2Y12 inhibitor (Prasugrel/Ticagrelor) to Clopidogrel in type 2 diabetes mellitus patients with AMI
30 August 2016 (08:30 - 12:30)
Organised by:
Abstract
About the speaker

Daejeon (Korea (Republic of))
22 More presentations in this session
Access the full session
The Event
ESC Congress 2016
30 August 2016
08:30 CET
